Accuracy of colorectal cancer ICD-9-CM codes in Italian administrative healthcare databases: a cross-sectional diagnostic study

Objectives To assess the accuracy of International Classification of Diseases, Ninth Revision – Clinical Modification (ICD-9-CM) codes in identifying subjects with colorectal cancer. Design A diagnostic accuracy study comparing ICD-9-CM codes (index test) for colorectal cancers with medical chart (as a reference standard). Case ascertainment based on neoplastic lesion(s) within the colon/rectum and histological documentation from a primary or metastatic site positive for colorectal cancer. Setting Administrative databases from the Umbria region, Azienda Sanitaria Locale (ASL) Napoli 3 Sud (NA) region and Friuli Venezia Giulia (FVG) region. Participants We randomly selected 130 incident patients from each hospital discharge database, admitted between 2012 and 2014, having colorectal cancer ICD-9 codes located in primary position, and 94 non-cases, that is, patients having a diagnosis of cancer (ICD-9 140–239) other than colorectal cancer in primary position. Outcome measures Sensitivity, specificity and predictive values for 153.x code (colon cancer) and for 154.x code (rectal cancer). Results The positive predictive value (PPV) for colon cancer diagnoses was 80% for Umbria (95% CI 73% to 87%), 81% for NA (95% CI 73% to 88%) and 80% for FVG (95% CI 72% to 87%). The sensitivity ranged from 98% to 99%, while the specificity ranged from 78% to 80% in the three units. For rectal cancer, the PPV was 84% for Umbria (95% CI 77% to 90%), 80% for NA (95% CI 72% to 87%) and 81% for FVG (95% CI 73% to 87%). The sensitivities ranged from 98% to 100%, while the specificity estimates from 79% to 82%. Conclusions Administrative databases in Italy can be a valuable tool for cancer surveillance as well as monitoring geographical and temporal variation of cancer practice.

[1]  D. Serraino,et al.  Accuracy of lung cancer ICD-9-CM codes in Umbria, Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study , 2018, BMJ Open.

[2]  D. Serraino,et al.  Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study , 2018, BMJ Open.

[3]  P. Bousquet,et al.  Recherche d’algorithmes d’identification des cancers dans les bases médico-administratives : premiers résultats des travaux du groupe REDSIAM Tumeurs sur les cancers du sein, du côlon-rectum et du poumon , 2017 .

[4]  A. Mengoni,et al.  Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: the Umbria Data Value Project , 2017, BMJ Open.

[5]  L. Antonuzzo,et al.  Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer , 2017, British Journal of Cancer.

[6]  Maria Laura Luchetta,et al.  Validity of peptic ulcer disease and upper gastrointestinal bleeding diagnoses in administrative databases: a systematic review protocol , 2016, BMJ Open.

[7]  Maria Laura Luchetta,et al.  Validation of chronic obstructive pulmonary disease (COPD) diagnoses in healthcare databases: a systematic review protocol , 2016, BMJ Open.

[8]  D. Serraino,et al.  Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol , 2016, BMJ Open.

[9]  Fabrizio Stracci,et al.  Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol , 2016, BMJ Open.

[10]  A. Deshpande,et al.  Development of a claims-based algorithm to identify colorectal cancer recurrence. , 2015, Annals of epidemiology.

[11]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[12]  Maria Laura Luchetta,et al.  The Current State of Validation of Administrative Healthcare Databases in Italy: A Systematic Review , 2014 .

[13]  Hermann Brenner,et al.  Colorectal cancer , 2014, The Lancet.

[14]  Ning Liu,et al.  Utilization and costs of home care for patients with colorectal cancer: a population-based study. , 2014, CMAJ open.

[15]  A. Dehal,et al.  Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database , 2013, Breast Cancer Research and Treatment.

[16]  H. Sørensen,et al.  Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. , 2012, European journal of cancer care.

[17]  M. Abrahamowicz,et al.  Estimation of National Colorectal-Cancer Incidence Using Claims Databases , 2012, Journal of cancer epidemiology.

[18]  Teresa To,et al.  Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. , 2011, Journal of clinical epidemiology.

[19]  E. Urso,et al.  Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months , 2009, Annals of Surgical Oncology.

[20]  C. Sacerdote,et al.  A high positive predictive value algorithm using hospital administrative data identified incident cancer cases. , 2008, Journal of clinical epidemiology.

[21]  Hude Quan,et al.  BMC Health Services Research BioMed Central Correspondence , 2006 .

[22]  A. Konski Clinical and Economic Outcomes Analyses of Women Developing Breast Cancer in a Managed Care Organization , 2005, American journal of clinical oncology.

[23]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, Annals of Internal Medicine.

[24]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[25]  P. Bousquet,et al.  [Using cancer case identification algorithms in medico-administrative databases: Literature review and first results from the REDSIAM Tumors group based on breast, colon, and lung cancer]. , 2017, Revue d'epidemiologie et de sante publique.

[26]  R. Labianca,et al.  Capecitabine versus Bolus Fluorouracil plus Leucovorin (Folinic Acid) as Adjuvant Chemotherapy for Patients with Dukes’ C Colon Cancer , 2008, Clinical drug investigation.

[27]  Abraham G. Hartzema,et al.  Pharmacoepidemiology and therapeutic risk management , 2008 .

[28]  Italian cancer figures--report 2006: 1. Incidence, mortality and estimates. , 2006, Epidemiologia e prevenzione.

[29]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.